Announcements Trials
Browse Landscape

Phase

Phase 1 14Phase 2 3Phase 1/2 2

Status

Completed 9Terminated 3Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 2Sarcoma 1Head & Neck 1CNS 1Breast 1

Conditions

Melanoma 2Squamous Cell Carcinoma of Head and Neck 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Terminated × poly ICLC × Clear all
NCT01437605 2019-12-20

Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
14 enrolled 9 charts
Dermatologic

Melanoma

NCT00052715 2018-07-18

Poly-ICLC

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
31 enrolled 8 charts
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01984892 2018-01-23

Hiltonol

Icahn School of Medicine at Mount Sinai

Phase 2 Terminated
8 enrolled 4 charts
BreastDermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡